Your session is about to expire
← Back to Search
Moving Well for Osteoarthritis
Study Summary
This trial will test whether a behavioral intervention can improve anxiety and depression levels for patients undergoing total knee arthroplasty.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You experience high levels of anxiety or depression, as measured by two questionnaires called GAD-7 and PHQ-8.You are able to travel to New York City (Upper East Side) for in-person data collection visits.You either have severe anxiety (score of 10 or higher on GAD-7) or depression (score of 10 or higher on PHQ-8).You have certain types of arthritis or connective tissue diseases like lupus, ankylosing spondylitis, psoriatic arthritis, scleroderma, infectious arthritis, or polymyalgia rheumatica.You have a primary (first) total knee replacement scheduled in 8 weeks or more.You had a knee replacement surgery because of a severe infection or an issue with the implant.
- Group 1: Moving Well
- Group 2: Staying Well
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities to participate in this trial still available?
"By referring to the data hosted on clinicaltrials.gov, it can be determined that this medical research is actively recruiting participants. This investigation was initially listed on April 5th 2022 and last altered on April 10th 2022."
What objectives does this medical investigation seek to achieve?
"The primary metric for evaluating the trial's success is a comparison of levels of depression between baseline and 6 months post-surgery, as measured by the Patient Health Questionnaire-8 (PHQ-8). Secondary assessments include an analysis of general health status via the 12-Item Short Form Survey (SF-12), self reported opioid use to manage knee pain, and overall changes in knee pain and function measuring with Knee Injury and Osteoarthritis Outcome Score (KOOS) subcales."
What is the aggregate tally of participants engaging in this research endeavor?
"Affirmative. Based on the information posted on clinicaltrials.gov, this medical study is still in active recruitment mode since it was first published April 5th 2022 and most recently amended April 10th 2022. This trial seeks 100 participants from a single location."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger